[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @VanMorrisMD Van Morris, MD Van Morris, MD posts on X about the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1296149160/interactions)  - X Week XXXXX +1,773% - X Month XXXXXX +103% - X Months XXXXXX +445% - X Year XXXXXX +273% ### Mentions: X [#](/creator/twitter::1296149160/posts_active)  ### Followers: XXXXX [#](/creator/twitter::1296149160/followers)  - X Week XXXXX +1.30% - X Month XXXXX +2.50% - X Months XXXXX +11% - X Year XXXXX +15% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1296149160/influencer_rank)  ### Social Influence [#](/creator/twitter::1296149160/influence) --- **Social category influence** [currencies](/list/currencies) ### Top Social Posts [#](/creator/twitter::1296149160/posts) --- Top posts by engagements in the last XX hours "Excellent talk from @EmerikOsterlund presenting research on ctDNA clearance patterns from pts w/ CRC in @MDAndersonNews INTERCEPT. Historical precedent for spontaneous ctDNA clearance using WES approach will help inform future trial design Accompanied by insightful perspective from the always incredible @aparna1024 . #endcancer" [X Link](https://x.com/VanMorrisMD/status/1979905891789885670) [@VanMorrisMD](/creator/x/VanMorrisMD) 2025-10-19T13:42Z 2511 followers, 2324 engagements "Does chemotherapy affect the biology of BRAF V600E mCRC when combined with encorafenib + ceruximab Answer appears to be YES Very intriguing translational finding showing that addition of chemo to E+C reduces development of acquired RAS MAP2K1 and other mutations that drive resistance to BRAF + EGFR blockade. Will use this data in counseling patients why we add chemo to E+C in this pt population. 👏 to BREAKWATER team for releasing translational data on their large XXX pt () analysis And congrats to the always amazing @skopetz for an incredible presentation- our @MDAndersonNews team remains so" [X Link](https://x.com/VanMorrisMD/status/1980167996027867399) [@VanMorrisMD](/creator/x/VanMorrisMD) 2025-10-20T07:03Z 2510 followers, 9125 engagements "🤯 🤯 Fantastic analysis of AtezoTRIBE and AVETRIC trials utilizing AI to predict benefit from IO in pts w/ MSS CRC- its wild that this biomarker work can be done from a single archival H&E slide. This approach will improve feasibility to analyze biomarkers in large multi-center trials moving forward. Industry should take note 👏 to @ChiaraCrem1 and study team" [X Link](https://x.com/VanMorrisMD/status/1980179738032497001) [@VanMorrisMD](/creator/x/VanMorrisMD) 2025-10-20T07:50Z 2510 followers, 3212 engagements "Interesting ph3 trial showing XXX month OS benefit with zanzalintinib+ atezolizumab vs rego in pts w/ treatment-ref MSS CRC- toxicity significant and excited to see more mature data in the future. Congrats to @AnwaarSaeed3 for leading this ph X trial" [X Link](https://x.com/VanMorrisMD/status/1980181159926521942) [@VanMorrisMD](/creator/x/VanMorrisMD) 2025-10-20T07:55Z 2510 followers, 5191 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@VanMorrisMD Van Morris, MDVan Morris, MD posts on X about the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence currencies
Top posts by engagements in the last XX hours
"Excellent talk from @EmerikOsterlund presenting research on ctDNA clearance patterns from pts w/ CRC in @MDAndersonNews INTERCEPT. Historical precedent for spontaneous ctDNA clearance using WES approach will help inform future trial design Accompanied by insightful perspective from the always incredible @aparna1024 . #endcancer"
X Link @VanMorrisMD 2025-10-19T13:42Z 2511 followers, 2324 engagements
"Does chemotherapy affect the biology of BRAF V600E mCRC when combined with encorafenib + ceruximab Answer appears to be YES Very intriguing translational finding showing that addition of chemo to E+C reduces development of acquired RAS MAP2K1 and other mutations that drive resistance to BRAF + EGFR blockade. Will use this data in counseling patients why we add chemo to E+C in this pt population. 👏 to BREAKWATER team for releasing translational data on their large XXX pt () analysis And congrats to the always amazing @skopetz for an incredible presentation- our @MDAndersonNews team remains so"
X Link @VanMorrisMD 2025-10-20T07:03Z 2510 followers, 9125 engagements
"🤯 🤯 Fantastic analysis of AtezoTRIBE and AVETRIC trials utilizing AI to predict benefit from IO in pts w/ MSS CRC- its wild that this biomarker work can be done from a single archival H&E slide. This approach will improve feasibility to analyze biomarkers in large multi-center trials moving forward. Industry should take note 👏 to @ChiaraCrem1 and study team"
X Link @VanMorrisMD 2025-10-20T07:50Z 2510 followers, 3212 engagements
"Interesting ph3 trial showing XXX month OS benefit with zanzalintinib+ atezolizumab vs rego in pts w/ treatment-ref MSS CRC- toxicity significant and excited to see more mature data in the future. Congrats to @AnwaarSaeed3 for leading this ph X trial"
X Link @VanMorrisMD 2025-10-20T07:55Z 2510 followers, 5191 engagements
/creator/twitter::VanMorrisMD